92 results on '"Młynarz P"'
Search Results
2. A single dose of glycogen phosphorylase inhibitor improves cognitive functions of aged mice and affects the concentrations of metabolites in the brain
- Author
-
Pudełko-Malik, Natalia, Drulis-Fajdasz, Dominika, Pruss, Łukasz, Mielko-Niziałek, Karolina Anna, Rakus, Dariusz, Gizak, Agnieszka, and Młynarz, Piotr
- Published
- 2024
- Full Text
- View/download PDF
3. Author Correction: Examination of internal metabolome and VOCs profile of brewery yeast and their mutants producing beer with improved aroma
- Author
-
Jabłoński, Sławomir Jan, Mielko-Niziałek, Karolina Anna, Leszczyński, Przemysław, Gasiński, Alan, Kawa-Rygielska, Joanna, Młynarz, Piotr, and Łukaszewicz, Marcin
- Published
- 2024
- Full Text
- View/download PDF
4. Examination of internal metabolome and VOCs profile of brewery yeast and their mutants producing beer with improved aroma
- Author
-
Jabłoński, Sławomir Jan, Mielko-Niziałek, Karolina Anna, Leszczyński, Przemysław, Gasiński, Alan, Kawa-Rygielska, Joanna, Młynarz, Piotr, and Łukaszewicz, Marcin
- Published
- 2024
- Full Text
- View/download PDF
5. The oxidative stress and metabolic response of Acinetobacter baumannii for aPDT multiple photosensitization
- Author
-
Wanarska, Ewelina, Mielko, Karolina Anna, Maliszewska, Irena, and Młynarz, Piotr
- Published
- 2022
- Full Text
- View/download PDF
6. Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus
- Author
-
Chojnacka, K., Witek-Krowiak, A., Skrzypczak, D., Mikula, K., and Młynarz, P.
- Published
- 2020
- Full Text
- View/download PDF
7. Brain-dead and coma patients exhibit different serum metabolic profiles: preliminary investigation of a novel diagnostic approach in neurocritical care
- Author
-
Dawiskiba, Tomasz, Wojtowicz, Wojciech, Qasem, Badr, Łukaszewski, Marceli, Mielko, Karolina Anna, Dawiskiba, Agnieszka, Banasik, Mirosław, Skóra, Jan Paweł, Janczak, Dariusz, and Młynarz, Piotr
- Published
- 2021
- Full Text
- View/download PDF
8. Comparison of bacteria disintegration methods and their influence on data analysis in metabolomics
- Author
-
Mielko, Karolina Anna, Jabłoński, Sławomir Jan, Łukaszewicz, Marcin, and Młynarz, Piotr
- Published
- 2021
- Full Text
- View/download PDF
9. Inclusive J/psi production in pp collisions at sqrt(s) = 2.76 TeV
- Author
-
ALICE Collaboration, Abelev, B., Adam, J., Adamova, D., Adare, A. M., Aggarwal, M. M., Rinella, G. Aglieri, Agocs, A. G., Agostinelli, A., Salazar, S. Aguilar, Ahammed, Z., Masoodi, A. Ahmad, Ahmad, N., Ahn, S. U., Akindinov, A., Aleksandrov, D., Alessandro, B., Molina, R. Alfaro, Alici, A., Alkin, A., Avina, E. Almaraz, Alme, J., Alt, T., Altini, V., Altinpinar, S., Altsybeev, I., Andrei, C., Andronic, A., Anguelov, V., Anielski, J., Anson, C., Anticic, T., Antinori, F., Antonioli, P., Aphecetche, L., Appelshauser, H., Arbor, N., Arcelli, S., Arend, A., Armesto, N., Arnaldi, R., Aronsson, T., Arsene, I. C., Arslandok, M., Asryan, A., Augustinus, A., Averbeck, R., Awes, T. C., Aysto, J., Azmi, M. D., Bach, M., Badala, A., Baek, Y. W., Bailhache, R., Bala, R., Ferroli, R. Baldini, Baldisseri, A., Baldit, A., Pedrosa, F. Baltasar Dos Santos, Ban, J., Baral, R. C., Barbera, R., Barile, F., Barnafoldi, G. G., Barnby, L. S., Barret, V., Bartke, J., Basile, M., Bastid, N., Bathen, B., Batigne, G., Batyunya, B., Baumann, C., Bearden, I. G., Beck, H., Belikov, I., Bellini, F., Bellwied, R., Belmont-Moreno, E., Bencedi, G., Beole, S., Berceanu, I., Bercuci, A., Berdnikov, Y., Berenyi, D., Bergmann, C., Berzano, D., Betev, L., Bhasin, A., Bhati, A. K., Bianchi, L., Bianchi, N., Bianchin, C., Bielcik, J., Bielcikova, J., Bjelogrlic, S., Blanco, F., Blau, D., Blume, C., Boccioli, M., Bock, N., Bogdanov, A., Boggild, H., Bogolyubsky, M., Boldizsar, L., Bombara, M., Book, J., Borel, H., Borissov, A., Bose, S., Bossu, F., Botje, M., Bottger, S., Boyer, B., Braidot, E., Braun-Munzinger, P., Bregant, M., Breitner, T., Browning, T. A., Broz, M., Brun, R., Bruna, E., Bruno, G. E., Budnikov, D., Buesching, H., Bufalino, S., Bugaiev, K., Busch, O., Buthelezi, Z., Orduna, D. Caballero, Caffarri, D., Cai, X., Caines, H., Villar, E. Calvo, Camerini, P., Roman, V. Canoa, Romeo, G. Cara, Carena, W., Carena, F., Filho, N. Carlin, Carminati, F., Montoya, C. A. Carrillo, Diaz, A. Casanova, Castellanos, J. Castillo, Hernandez, J. F. Castillo, Casula, E. A. R., Catanescu, V., Cavicchioli, C., Cepila, J., Cerello, P., Chang, B., Chapeland, S., Charvet, J. L., Chattopadhyay, S., Chawla, I., Cherney, M., Cheshkov, C., Cheynis, B., Chiavassa, E., Barroso, V. Chibante, Chinellato, D. D., Chochula, P., Chojnacki, M., Christakoglou, P., Christensen, C. H., Christiansen, P., Chujo, T., Chung, S. U., Cicalo, C., Cifarelli, L., Cindolo, F., Cleymans, J., Coccetti, F., Colamaria, F., Colella, D., Balbastre, G. Conesa, del Valle, Z. Conesa, Constantin, P., Contin, G., Contreras, J. G., Cormier, T. M., Morales, Y. Corrales, Cortese, P., Maldonado, I. Cortes, Cosentino, M. R., Costa, F., Cotallo, M. E., Crescio, E., Crochet, P., Alaniz, E. Cruz, Cuautle, E., Cunqueiro, L., Dainese, A., Dalsgaard, H. H., Danu, A., Das, K., Das, I., Das, D., Dash, A., Dash, S., De, S., de Barros, G. O. V., De Caro, A., de Cataldo, G., de Cuveland, J., De Falco, A., De Gruttola, D., Delagrange, H., Sanchez, E. Del Castillo, Deloff, A., Demanov, V., De Marco, N., Denes, E., De Pasquale, S., Deppman, A., Erasmo, G. D, de Rooij, R., Corchero, M. A. Diaz, Di Bari, D., Dietel, T., Di Giglio, C., Di Liberto, S., Di Mauro, A., Di Nezza, P., Divia, R., Djuvsland, O., Dobrin, A., Dobrowolski, T., Dominguez, I., Donigus, B., Dordic, O., Driga, O., Dubey, A. K., Ducroux, L., Dupieux, P., Majumdar, A. K. Dutta, Majumdar, M. R. Dutta, Elia, D., Emschermann, D., Engel, H., Erdal, H. A., Espagnon, B., Estienne, M., Esumi, S., Evans, D., Eyyubova, G., Fabris, D., Faivre, J., Falchieri, D., Fantoni, A., Fasel, M., Fearick, R., Fedunov, A., Fehlker, D., Feldkamp, L., Felea, D., Feofilov, G., Tellez, A. Fernandez, Ferreiro, E. G., Ferretti, A., Ferretti, R., Figiel, J., Figueredo, M. A. S., Filchagin, S., Finogeev, D., Fionda, F. M., Fiore, E. M., Floris, M., Foertsch, S., Foka, P., Fokin, S., Fragiacomo, E., Fragkiadakis, M., Frankenfeld, U., Fuchs, U., Furget, C., Girard, M. Fusco, Gaardhoje, J. J., Gagliardi, M., Gago, A., Gallio, M., Gangadharan, D. R., Ganoti, P., Garabatos, C., Garcia-Solis, E., Garishvili, I., Gerhard, J., Germain, M., Geuna, C., Gheata, A., Gheata, M., Ghidini, B., Ghosh, P., Gianotti, P., Girard, M. R., Giubellino, P., Gladysz-Dziadus, E., Glassel, P., Gomez, R., Gonzalez-Trueba, L. H., Gonzalez-Zamora, P., Gorbunov, S., Goswami, A., Gotovac, S., Grabski, V., Graczykowski, L. K., Grajcarek, R., Grelli, A., Grigoras, A., Grigoras, C., Grigoriev, V., Grigoryan, A., Grigoryan, S., Grinyov, B., Grion, N., Gros, P., Grosse-Oetringhaus, J. F., Grossiord, J. -Y., Grosso, R., Guber, F., Guernane, R., Gutierrez, C. Guerra, Guerzoni, B., Guilbaud, M., Gulbrandsen, K., Gunji, T., Gupta, A., Gupta, R., Gutbrod, H., Haaland, O., Hadjidakis, C., Haiduc, M., Hamagaki, H., Hamar, G., Han, B. H., Hanratty, L. D., Hansen, A., Harmanova, Z., Harris, J. W., Hartig, M., Hasegan, D., Hatzifotiadou, D., Hayrapetyan, A., Heckel, S. T., Heide, M., Helstrup, H., Herghelegiu, A., Corral, G. Herrera, Herrmann, N., Hetland, K. F., Hicks, B., Hille, P. T., Hippolyte, B., Horaguchi, T., Hori, Y., Hristov, P., Hrivnacova, I., Huang, M., Huber, S., Humanic, T. J., Hwang, D. S., Ichou, R., Ilkaev, R., Ilkiv, I., Inaba, M., Incani, E., Innocenti, G. M., Innocenti, P. G., Ippolitov, M., Irfan, M., Ivan, C., Ivanov, V., Ivanov, A., Ivanov, M., Ivanytskyi, O., Jacholkowski, A., Jacobs, P. M., Jancurova, L., Jang, H. J., Jangal, S., Janik, M. A., Janik, R., Jayarathna, P. H. S. Y., Jena, S., Bustamante, R. T. Jimenez, Jirden, L., Jones, P. G., Jung, H., Jusko, A., Kaidalov, A. B., Kakoyan, V., Kalcher, S., Kalinak, P., Kalisky, M., Kalliokoski, T., Kalweit, A., Kanaki, K., Kang, J. H., Kaplin, V., Uysal, A. Karasu, Karavichev, O., Karavicheva, T., Karpechev, E., Kazantsev, A., Kebschull, U., Keidel, R., Khan, M. M., Khan, S. A., Khan, P., Khanzadeev, A., Kharlov, Y., Kileng, B., Kim, M., Kim, J. S., Kim, D. J., Kim, T., Kim, B., Kim, S., Kim, S. H., Kim, D. W., Kim, J. H., Kirsch, S., Kisel, I., Kiselev, S., Kisiel, A., Klay, J. L., Klein, J., Klein-Bosing, C., Kliemant, M., Kluge, A., Knichel, M. L., Knospe, A. G., Koch, K., Kohler, M. K., Kolojvari, A., Kondratiev, V., Kondratyeva, N., Konevskikh, A., Korneev, A., Don, C. Kottachchi Kankanamge, Kour, R., Kowalski, M., Kox, S., Meethaleveedu, G. Koyithatta, Kral, J., Kralik, I., Kramer, F., Kraus, I., Krawutschke, T., Krelina, M., Kretz, M., Krivda, M., Krizek, F., Krus, M., Kryshen, E., Krzewicki, M., Kucheriaev, Y., Kuhn, C., Kuijer, P. G., Kurashvili, P., Kurepin, A., Kurepin, A. B., Kuryakin, A., Kushpil, S., Kushpil, V., Kvaerno, H., Kweon, M. J., Kwon, Y., de Guevara, P. Ladron, Lakomov, I., Langoy, R., Lara, C., Lardeux, A., La Rocca, P., Lazzeroni, C., Lea, R., Bornec, Y. Le, Lee, S. C., Lee, K. S., Lefevre, F., Lehnert, J., Leistam, L., Lenhardt, M., Lenti, V., Leon, H., Monzon, I. Leon, Vargas, H. Leon, Levai, P., Lien, J., Lietava, R., Lindal, S., Lindenstruth, V., Lippmann, C., Lisa, M. A., Liu, L., Loenne, P. I., Loggins, V. R., Loginov, V., Lohn, S., Lohner, D., Loizides, C., Loo, K. K., Lopez, X., Torres, E. Lopez, Lovhoiden, G., Lu, X. -G., Luettig, P., Lunardon, M., Luo, J., Luparello, G., Luquin, L., Luzzi, C., Ma, K., Ma, R., Madagodahettige-Don, D. M., Maevskaya, A., Mager, M., Mahapatra, D. P., Maire, A., Malaev, M., Cervantes, I. Maldonado, Malinina, L., Mal'Kevich, D., Malzacher, P., Mamonov, A., Manceau, L., Mangotra, L., Manko, V., Manso, F., Manzari, V., Mao, Y., Marchisone, M., Mares, J., Margagliotti, G. V., Margotti, A., Marin, A., Tobon, C. A. Marin, Markert, C., Martashvili, I., Martinengo, P., Martinez, M. I., Davalos, A. Martinez, Garcia, G. Martinez, Martynov, Y., Mas, A., Masciocchi, S., Masera, M., Masoni, A., Massacrier, L., Mastromarco, M., Mastroserio, A., Matthews, Z. L., Matyja, A., Mayani, D., Mayer, C., Mazer, J., Mazzoni, M. A., Meddi, F., Menchaca-Rocha, A., Perez, J. Mercado, Meres, M., Miake, Y., Milano, L., Milosevic, J., Mischke, A., Mishra, A. N., Miskowiec, D., Mitu, C., Mlynarz, J., Mohanty, A. K., Mohanty, B., Molnar, L., Zetina, L. Montano, Monteno, M., Montes, E., Moon, T., Morando, M., De Godoy, D. A. Moreira, Moretto, S., Morsch, A., Muccifora, V., Mudnic, E., Muhuri, S., Muller, H., Munhoz, M. G., Musa, L., Musso, A., Nandi, B. K., Nania, R., Nappi, E., Nattrass, C., Naumov, N. P., Navin, S., Nayak, T. K., Nazarenko, S., Nazarov, G., Nedosekin, A., Nicassio, M., Nielsen, B. S., Niida, T., Nikolaev, S., Nikolic, V., Nikulin, V., Nikulin, S., Nilsen, B. S., Nilsson, M. S., Noferini, F., Nomokonov, P., Nooren, G., Novitzky, N., Nyanin, A., Nyatha, A., Nygaard, C., Nystrand, J., Ochirov, A., Oeschler, H., Oh, S. K., Oh, S., Oleniacz, J., Oppedisano, C., Velasquez, A. Ortiz, Ortona, G., Oskarsson, A., Ostrowski, P., Otwinowski, J., Ovrebekk, G., Oyama, K., Ozawa, K., Pachmayer, Y., Pachr, M., Padilla, F., Pagano, P., Paic, G., Painke, F., Pajares, C., Pal, S. K., Pal, S., Palaha, A., Palmeri, A., Papikyan, V., Pappalardo, G. S., Park, W. J., Passfeld, A., Pastircak, B., Patalakha, D. I., Paticchio, V., Pavlinov, A., Pawlak, T., Peitzmann, T., Filho, E. Pereira De Oliveira, Peresunko, D., Lara, C. E. Perez, Lezama, E. Perez, Perini, D., Perrino, D., Peryt, W., Pesci, A., Peskov, V., Pestov, Y., Petracek, V., Petran, M., Petris, M., Petrov, P., Petrovici, M., Petta, C., Piano, S., Piccotti, A., Pikna, M., Pillot, P., Pinazza, O., Pinsky, L., Pitz, N., Piuz, F., Piyarathna, D. B., Ploskon, M., Pluta, J., Pocheptsov, T., Pochybova, S., Podesta-Lerma, P. L. M., Poghosyan, M. G., Polak, K., Polichtchouk, B., Pop, A., Porteboeuf-Houssais, S., Pospisil, V., Potukuchi, B., Prasad, S. K., Preghenella, R., Prino, F., Pruneau, C. A., Pshenichnov, I., Puchagin, S., Puddu, G., Teixido, J. Pujol, Pulvirenti, A., Punin, V., Putis, M., Putschke, J., Quercigh, E., Qvigstad, H., Rachevski, A., Rademakers, A., Radomski, S., Raiha, T. S., Rak, J., Rakotozafindrabe, A., Ramello, L., Reyes, A. Ramirez, Raniwala, S., Raniwala, R., Rasanen, S. S., Rascanu, B. T., Rathee, D., Read, K. F., Real, J. S., Redlich, K., Reichelt, P., Reicher, M., Renfordt, R., Reolon, A. R., Reshetin, A., Rettig, F., Revol, J. -P., Reygers, K., Riccati, L., Ricci, R. A., Richert, T., Richter, M., Riedler, P., Riegler, W., Riggi, F., Cahuantzi, M. Rodriguez, Roed, K., Rohr, D., Rohrich, D., Romita, R., Ronchetti, F., Rosnet, P., Rossegger, S., Rossi, A., Roukoutakis, F., Roy, C., Roy, P., Montero, A. J. Rubio, Rui, R., Ryabinkin, E., Rybicki, A., Sadovsky, S., Safarik, K., Sahoo, R., Sahu, P. K., Saini, J., Sakaguchi, H., Sakai, S., Sakata, D., Salgado, C. A., Salzwedel, J., Sambyal, S., Samsonov, V., Castro, X. Sanchez, Sandor, L., Sandoval, A., Sano, S., Sano, M., Santo, R., Santoro, R., Sarkamo, J., Scapparone, E., Scarlassara, F., Scharenberg, R. P., Schiaua, C., Schicker, R., Schmidt, H. R., Schmidt, C., Schreiner, S., Schuchmann, S., Schukraft, J., Schutz, Y., Schwarz, K., Schweda, K., Scioli, G., Scomparin, E., Scott, P. A., Scott, R., Segato, G., Selyuzhenkov, I., Senyukov, S., Seo, J., Serci, S., Serradilla, E., Sevcenco, A., Sgura, I., Shabetai, A., Shabratova, G., Shahoyan, R., Sharma, N., Sharma, S., Shigaki, K., Shimomura, M., Shtejer, K., Sibiriak, Y., Siciliano, M., Sicking, E., Siddhanta, S., Siemiarczuk, T., Silvermyr, D., Silvestre, C., Simonetti, G., Singaraju, R., Singh, R., Singha, S., Sinha, T., Sinha, B. C., Sitar, B., Sitta, M., Skaali, T. B., Skjerdal, K., Smakal, R., Smirnov, N., Snellings, R. J. M., Sogaard, C., Soltz, R., Son, H., Song, M., Song, J., Soos, C., Soramel, F., Sputowska, I., Spyropoulou-Stassinaki, M., Srivastava, B. K., Stachel, J., Stan, I., Stefanek, G., Stefanini, G., Steinbeck, T., Steinpreis, M., Stenlund, E., Steyn, G., Stocco, D., Stolpovskiy, M., Strabykin, K., Strmen, P., Suaide, A. A. P., Vasquez, M. A. Subieta, Sugitate, T., Suire, C., Sukhorukov, M., Sultanov, R., Sumbera, M., Susa, T., de Toledo, A. Szanto, Szarka, I., Szostak, A., Tagridis, C., Takahashi, J., Takaki, J. D. Tapia, Tauro, A., Munoz, G. Tejeda, Telesca, A., Terrevoli, C., Thader, J., Thomas, D., Tieulent, R., Timmins, A. R., Tlusty, D., Toia, A., Torii, H., Toscano, L., Tosello, F., Truesdale, D., Trzaska, W. H., Tsuji, T., Tumkin, A., Turrisi, R., Tveter, T. S., Ulery, J., Ullaland, K., Ulrich, J., Uras, A., Urban, J., Urciuoli, G. M., Usai, G. L., Vajzer, M., Vala, M., Palomo, L. Valencia, Vallero, S., van der Kolk, N., Vyvre, P. Vande, van Leeuwen, M., Vannucci, L., Vargas, A., Varma, R., Vasileiou, M., Vasiliev, A., Vechernin, V., Veldhoen, M., Venaruzzo, M., Vercellin, E., Vergara, S., Vernekohl, D. C., Vernet, R., Verweij, M., Vickovic, L., Viesti, G., Vikhlyantsev, O., Vilakazi, Z., Baillie, O. Villalobos, Vinogradov, A., Vinogradov, Y., Vinogradov, L., Virgili, T., Viyogi, Y. P., Vodopyanov, A., Voloshin, S., Voloshin, K., Volpe, G., von Haller, B., Vranic, D., Vrlakova, J., Vulpescu, B., Vyushin, A., Wagner, B., Wagner, V., Wan, R., Wang, Y., Wang, D., Wang, M., Watanabe, K., Wessels, J. P., Westerhoff, U., Wiechula, J., Wikne, J., Wilde, M., Wilk, G., Wilk, A., Williams, M. C. S., Windelband, B., Karampatsos, L. Xaplanteris, Yang, H., Yang, S., Yasnopolskiy, S., Yi, J., Yin, Z., Yokoyama, H., Yoo, I. -K., Yoon, J., Yu, W., Yuan, X., Yushmanov, I., Zach, C., Zampolli, C., Zaporozhets, S., Zarochentsev, A., Zavada, P., Zaviyalov, N., Zbroszczyk, H., Zelnicek, P., Zgura, I. S., Zhalov, M., Zhang, X., Zhou, D., Zhou, Y., Zhou, F., Zhu, X., Zichichi, A., Zimmermann, A., Zinovjev, G., Zoccarato, Y., and Zynovyev, M.
- Subjects
High Energy Physics - Experiment - Abstract
The ALICE Collaboration has measured inclusive J/psi production in pp collisions at a center of mass energy sqrt(s)=2.76 TeV at the LHC. The results presented in this Letter refer to the rapidity ranges |y|<0.9 and 2.5
- Published
- 2012
- Full Text
- View/download PDF
10. Serum metabolomics approach to monitor the changes in metabolite profiles following renal transplantation
- Author
-
Stanimirova, Ivana, Banasik, Mirosław, Ząbek, Adam, Dawiskiba, Tomasz, Kościelska-Kasprzak, Katarzyna, Wojtowicz, Wojciech, Krajewska, Magdalena, Janczak, Dariusz, and Młynarz, Piotr
- Published
- 2020
- Full Text
- View/download PDF
11. Metabolomic studies of Pseudomonas aeruginosa
- Author
-
Mielko, Karolina Anna, Jabłoński, Sławomir Jan, Milczewska, Justyna, Sands, Dorota, Łukaszewicz, Marcin, and Młynarz, Piotr
- Published
- 2019
- Full Text
- View/download PDF
12. Metabolomic studies as a tool for determining the post-mortem interval (PMI) in stillborn calves
- Author
-
Jawor, Paulina, Ząbek, Adam, Wojtowicz, Wojciech, Król, Dawid, Stefaniak, Tadeusz, and Młynarz, Piotr
- Published
- 2019
- Full Text
- View/download PDF
13. Biodiversity in targeted metabolomics analysis of filamentous fungal pathogens by 1H NMR-based studies
- Author
-
Ząbek, Adam, Klimek-Ochab, Magdalena, Jawień, Ewa, and Młynarz, Piotr
- Published
- 2017
- Full Text
- View/download PDF
14. Using Metabolomics to Monitor Kidney Transplantation Patients by Means of Clustering to Spot Anomalous Patient Behavior
- Author
-
Calderisi, M., Vivi, A., Mlynarz, P., Tassin, M., Banasik, M., Dawiskiba, T., and Carmellini, M.
- Published
- 2013
- Full Text
- View/download PDF
15. Predisposition to atherosclerosis in children and adults with trisomy 21: biochemical and metabolomic studies.
- Author
-
Hetman, Marta, Mielko, Karolina, Placzkowska, Sylwia, Bodetko, Aleksandra, Młynarz, Piotr, and Barg, Ewa
- Subjects
DOWN syndrome ,APOLIPOPROTEIN B ,APOLIPOPROTEIN A ,METABOLOMICS ,LIPID metabolism ,THREONINE ,TYROSINE - Abstract
Introduction: Atherosclerosis, a precursor to cardiovascular disease (CVD), is deeply intertwined with lipid metabolism. The metabolic process in the Down syndrome (DS) population remain less explored. Aim of the study: This study examines the lipid profiles of DS in comparison to their siblings (CG), aiming to uncover potential atherosclerotic and CVD risks. Material and methods: The study included 42 people with DS (mean age 14.17 years) and the CG - 20 individuals (mean age 15.92 years). Anthropometric measurements: BMI, BMI SDS, and TMI were calculated. Lipid profile (LP) and metabolomics were determined. Results: LP: DS display significantly reduced HDL (DS vs. CG: 47±10 vs. 59 ±12 mg/dl; p = 0.0001) and elevated LDL (104 ±25 vs. 90 ±22 mg/dl; p = 0.0331). Triglycerides, APO A1, and APO B/APO A1 ratio corroborate with the elevated risk of CVD in DS. Despite no marked differences in: TCH and APO B, the DS group demonstrated a concerning BMI trend. Of 31 identified metabolites, 12 showed statistical significance (acetate, choline, creatinine, formate, glutamine, histidine, lysine, proline, pyroglutamate, threonine, tyrosine, and xanthine). However, only 8 metabolites passed the FDR validation (acetate, creatinine, formate, glutamine, lysine, proline, pyroglutamate, xanthine). Conclusions: Down syndrome individuals show distinct cardiovascular risks, with decreased HDL and increased LDL levels. Combined with metabolomic disparities and higher BMI and TMI, this suggests an increased atherosclerosis risk compared to controls. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Fusion of the 1H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructive sleep apnea syndrome
- Author
-
Ząbek, Adam, Stanimirova, Ivana, Deja, Stanisław, Barg, Wojciech, Kowal, Aneta, Korzeniewska, Anna, Orczyk-Pawiłowicz, Magdalena, Baranowski, Daniel, Gdaniec, Zofia, Jankowska, Renata, and Młynarz, Piotr
- Published
- 2015
- Full Text
- View/download PDF
17. Activity of fluconazole and its Cu(II) complex towards Candida species
- Author
-
Ząbek, Adam, Nagaj, Justyna, Grabowiecka, Agnieszka, Dworniczek, Ewa, Nawrot, Urszula, Młynarz, Piotr, and Jeżowska-Bojczuk, Małgorzata
- Published
- 2015
- Full Text
- View/download PDF
18. Structural studies of Cu(II) binding to the novel peptidyl derivative of quinoxaline: N-(3-(2,3-di(pyridin-2-yl)quinoxalin-6-yl)alanyl)glycine
- Author
-
Szczepanik, W., Młynarz, P., Stefanowicz, P., Kucharczyk-Klamińska, M., D’Amelio, N., Olbert-Majkut, A., Staszewska, A., Ratajska, M., Szewczuk, Z., and Jeżowska-Bojczuk, M.
- Published
- 2011
- Full Text
- View/download PDF
19. Linear and Nonlinear Optical Properties of Azobenzene Derivatives Modified with an (Amino)naphthalene Moiety.
- Author
-
Dudek, Marta, Kaczmarek-Kędziera, Anna, Deska, Radosław, Trojnar, Jakub, Jasik, Patryk, Młynarz, Piotr, Samoć, Marek, and Matczyszyn, Katarzyna
- Published
- 2022
- Full Text
- View/download PDF
20. Rapid determination of ibotenic acid and muscimol in human urine
- Author
-
Deja, S., primary, Jawień, E., additional, Jasicka-Misiak, I., additional, Halama, M., additional, Wieczorek, P., additional, Kafarski, P., additional, and Młynarz, P., additional
- Published
- 2014
- Full Text
- View/download PDF
21. Metabolomics provides new information on the changes occurring in thyroid tumours
- Author
-
Balcerzak, Waldemar, primary, Deja, S, additional, Młynarz, P, additional, Ząbek, A, additional, Orczyk-Pawiłowicz, M, additional, Głód, M, additional, Dawiskiba, T, additional, and Pawełka, D, additional
- Published
- 2013
- Full Text
- View/download PDF
22. Cu<SUP>II</SUP> Ion Coordination to an Unprotected Pentadecapeptide Containing Two His Residues: Competition Between the Terminal Amino and the Side-Chain Imidazole Nitrogen Donors
- Author
-
Conato, Chiara, Kamysz, Wojciech, Kozłowski, Henryk, Łuczkowski, Marek, Mackiewicz, Zbigniew, Mancini, Francesca, Młynarz, Piotr, Remelli, Maurizio, Valensin, Daniela, and Valensin, Gianni
- Abstract
The complex-formation equilibria of the pentadecapeptide TLEGTKKGHKLHLDY, the 114−128 protein fragment of SPARC, with the CuII ion have been investigated, at I = 0.1 mol·dm−3 (KNO
3 ) and T = 298.2 K. Protonation and complex-formation constants have been determined potentiometrically, and formation enthalpies measured by direct solution calorimetry; the complex-formation model and species stoichiometry have been carefully checked by means of UV/Vis absorption, CD and EPR spectroscopy. The structure hypotheses of the complex species are also based on detailed study of the 1H and 13C NMR spectra of the ligand in both the absence and presence of copper ions. The involvement in complex-formation of both the terminal amino and imidazole groups has been suggested and their specific behaviour at different pH values elucidated. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)- Published
- 2003
- Full Text
- View/download PDF
23. Cu(ii) ion coordination to the pentadecapeptide model of the SPARC copper-binding site
- Author
-
Conato, Chiara, Kamysz, Wojciech, Kozłowski, Henryk, Łuczkowski, Marek, Mackiewicz, Zbigniew, Młynarz, Piotr, Remelli, Maurizio, Valensin, Daniela, and Valensin, Gianni
- Abstract
SPARC (Secreted Protein, Acidic and Rich in Cysteine) is a matricellular glycoprotein with many biological functions: it mediates the interactions between cells and the extracellular matrix, playing a role in angiogenesis, tumorigenesis, caractogenesis and wound healing. Proteolysis of SPARC gives rise to a number of oligopeptides which can regulate angiogenesis in vivo and the biological activity of which has been related to their association with endogenous or exogenous copper ion. Human SPARC consists of three distinct modules. Module II is follistatin-like and contains two copper binding sites, the strongest of whichthe cationic region 2 (amino acids 114130)contains the sequence GlyHisLys. In order to shed more light on the biological role of metal complexes formed by SPARC and its fragments, more information is needed on their stoichiometry, stability and structure in solution. In the present paper a potentiometric and spectroscopic investigation on Cu(ii) complexes with the SPARC114128 fragment, protected at both its amino and carboxylic ends, is reported. This peptide (AcTLEGTKKGHKLHLDYNH2) constitutes a good model to the strong copper-binding site of the protein. The whole experimental data suggest that complex-formation is started by the two His residues, subsequently involving up to three amido nitrogens, as pH increases. The coordination of the two histydyl imidazoles is able to promote amide ionisation in the physiological pH range and this could be the key to the SPARC affinity for Cu(ii) ion.
- Published
- 2002
24. Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity
- Author
-
Conato, Chiara, Gavioli, Riccardo, Guerrini, Remo, Kozłowski, Henryk, Młynarz, Piotr, Pasti, Claudia, Pulidori, Fernando, and Remelli, Maurizio
- Abstract
Copper complex formation equilibria of glycyl-L-histidyl-L-lysine (Gly-His-Lys, GHK) and of two synthetic analogues, where the histidine residue was replaced with a synthetic amino acid (L-spinacine or L-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid), have been carefully investigated using different experimental techniques: potentiometry, solution calorimetry, UV-VIS spectrophotometry, circular dichroism and electron paramagnetic resonance spectroscopies. All the ligands formed complexes having different stoichiometries and stabilities; evidence for the formation of binuclear species is also shown. The structures of the main complexes are discussed. It is suggested that the lateral lysine amino group participates in complex formation, but only at alkaline pH values: at physiological pH this group is protonated and available for possible interactions with cellular receptors. The above tripeptides have been tested for their enzymatic stability in human serum: the synthetic compounds showed no significant degradation for at least 3 h. Finally, their activity as growth factor has been studied in vitro. The two synthetic analogues showed an activity comparable to or even higher than that of GHK, thus suggesting their possible use as additives in cell culture media, even in the presence of serum. Relevant information on the GHK action mechanism as cell growth factor has been obtained: the formation of copper complexes, driven by the first (Gly) residue, appears necessary while the second residue (His) does not appear to play a specific role; the presence of the free side chain of the third residue (Lys) appears to be of fundamental importance.
- Published
- 2001
- Full Text
- View/download PDF
25. Impact of α-hydroxymethylserine (HmS) residue on the binding ability of the histidyl residue in the HmS-His dipeptide towards CuII, NiII and ZnII
- Author
-
Młynarz, Piotr, Kowalik-Jankowska, Teresa, Stasiak, Marcin, T. Leplawy, Mirosław, and Kozłowski, Henryk
- Abstract
Potentiometric and spectroscopic data have shown that α-hydroxymethylserylhistidine is a very efficient ligand for CuII, NiII and ZnII. The stabilities of the complexes formed are considerably higher than those obtained for Gly-His or Ala-His dipeptides. Copper(II) and NiII form very stable tetrameric complexes M4H–8L4. According to 1H NMR spectra the nickel tetrameric complex is of C2 symmetry with two pairs of different imidazole rings. Zinc(II), on the other hand, forms only monomeric species but due to the second His residue it forms very stable ZnH–1L species via a {NH2,N–amide,Nimidazole} donor set.
- Published
- 1999
- Full Text
- View/download PDF
26. Fly agaric (Amanita muscaria) as promising source of ergosterol,Muchomor czerwony (Amanita muscaria) jako obiecujace źró dło ergosterolu
- Author
-
Maciejczyk, E., Jasicka-Misiak, I., Młynarz, P., Tadeusz Lis, Wieczorek, P. P., and Kafarski, P.
27. Introduction of α-hydroxymethylserine residues in a peptide sequence results in the strongest peptidic, albumin-like, copper(II) chelator known to date
- Author
-
Młynarz, Piotr, Bal, Wojciech, Kowalik-Jankowska, Teresa, Stasiak, Marcin, T. Leplawy, Mirosław, and Kozłowski, Henryk
- Abstract
A tripetide amide HmS-HmS-His-NH2 is the strongest peptidic CuII chelator known to date, due to the steric shielding of the chelate plane as well as electronic effects.
- Published
- 1999
- Full Text
- View/download PDF
28. Chiral peptide nucleic acids: a new family of ligands for metal ions
- Author
-
Szyrwiel, Justyna, Młynarz, Piotr, Kozłowski, Henryk, and Taddei, Maurizio
- Abstract
The first studies on peptide nucleic acid co-ordination abilities towards Cu2+ ions indicated that when nucleobases were present in the amino acid residue side chain the interactions between the nucleic bases induced very effective metal-ion binding by the peptide backbone donor system.
- Published
- 1998
- Full Text
- View/download PDF
29. Bioelectrochemical synthesis of rhamnolipids and energy production and its correlation with nitrogen in air-cathode microbial fuel cells.
- Author
-
de Rosset A, Tyszkiewicz N, Wiśniewski J, Pudełko-Malik N, Rutkowski P, Młynarz P, and Pasternak G
- Subjects
- Electrodes, Bioreactors, Bioelectric Energy Sources, Nitrogen metabolism, Surface-Active Agents metabolism, Glycolipids metabolism
- Abstract
Microbial fuel cells (MFCs) have been recently proven to synthesise biosurfactants from waste products. In classic bioreactors, the efficiency of biosynthesis process can be controlled by the concentration of nitrogen content in the electrolyte. However, it was not known whether a similar control mechanism could be applied in current-generating conditions. In this work, the effect of nitrogen concentration on biosurfactant production from waste cooking oil was investigated. The concentration of NH
4 Cl in the electrolyte ranged from 0 to 1 g L-1 . The maximum power density equal to 17.5 W m-3 was achieved at a concentration of 0.5 g L-1 (C/N = 2.32) and was accompanied by the highest surface tension decrease (to 54.6 mN m-1 ) and an emulsification activity index of 95.4%. Characterisation of the biosurfactants produced by the LC-MS/MS method showed the presence of eleven compounds belonging to the mono- and di-rhamnolipids group, most likely produced by P. aeruginosa, which was the most abundant (19.6%) in the community. Importantly, we have found a strong correlation (R = -0.96) of power and biosurfactant activity in response to C/N ratio. This study shows that nitrogen plays an important role in the current-generating metabolism of waste cooking oil. To the best of our knowledge, this is the first study where the nitrogen optimisation was investigated to improve the synthesis of biosurfactants and power generation in a bioelectrochemical system., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
30. The influence of benzene on the composition, diversity and performance of the anodic bacterial community in glucose-fed microbial fuel cells.
- Author
-
Tyszkiewicz N, Truu J, Młynarz P, and Pasternak G
- Abstract
Bioelectrochemical systems offer unique opportunities to remove recalcitrant environmental pollutants in a net positive energy process, although it remains challenging because of the toxic character of such compounds. In this study, microbial fuel cell (MFC) technology was applied to investigate the benzene degradation process for more than 160 days, where glucose was used as a co-metabolite and a control. We have applied an inoculation strategy that led to the development of 10 individual microbial communities. The electrochemical dynamics of MFC efficiency was observed, along with their
1 H NMR metabolic fingerprints and analysis of the microbial community. The highest power density of 120 mW/m2 was recorded in the final period of the experiment when benzene/glucose was used as fuel. This is the highest value reported in a benzene/co-substrate system. Metabolite analysis confirmed the full removal of benzene, while the dominance of fermentation products indicated the strong occurrence of non-electrogenic reactions. Based on 16S rRNA gene amplicon sequencing, bacterial community analysis revealed several petroleum-degrading microorganisms, electroactive species and biosurfactant producers. The dominant species were recognised as Citrobacter freundii and Arcobacter faecis . Strong, positive impact of the presence of benzene on the alpha diversity was recorded, underlining the high complexity of the bioelectrochemically supported degradation of petroleum compounds. This study reveals the importance of supporting the bioelectrochemical degradation process with auxiliary substrates and inoculation strategies that allow the communities to reach sufficient diversity to improve the power output and degradation efficiency in MFCs beyond the previously known limits. This study, for the first time, provides an outlook on the syntrophic activity of biosurfactant producers and petroleum degraders towards the efficient removal and conversion of recalcitrant hydrophobic compounds into electricity in MFCs., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision., (Copyright © 2024 Tyszkiewicz, Truu, Młynarz and Pasternak.)- Published
- 2024
- Full Text
- View/download PDF
31. Glycogen phosphorylase inhibition improves cognitive function of aged mice.
- Author
-
Drulis-Fajdasz D, Krzystyniak A, Puścian A, Pytyś A, Gostomska-Pampuch K, Pudełko-Malik N, Wiśniewski JŁ, Młynarz P, Miazek A, Wójtowicz T, Włodarczyk J, Duś-Szachniewicz K, Gizak A, Wiśniewski JR, and Rakus D
- Subjects
- Mice, Animals, Memory Disorders metabolism, Cognition, Glycogen metabolism, Dendritic Spines metabolism, Hippocampus metabolism, Glycogen Phosphorylase metabolism
- Abstract
Inhibition of glycogen breakdown blocks memory formation in young animals, but it stimulates the maintenance of the long-term potentiation, a cellular mechanism of memory formation, in hippocampal slices of old animals. Here, we report that a 2-week treatment with glycogen phosphorylase inhibitor BAY U6751 alleviated memory deficits and stimulated neuroplasticity in old mice. Using the 2-Novel Object Recognition and Novel Object Location tests, we discovered that the prolonged intraperitoneal administration of BAY U6751 improved memory formation in old mice. This was accompanied by changes in morphology of dendritic spines in hippocampal neurons, and by "rejuvenation" of hippocampal proteome. In contrast, in young animals, inhibition of glycogen degradation impaired memory formation; however, as in old mice, it did not alter significantly the morphology and density of cortical dendritic spines. Our findings provide evidence that prolonged inhibition of glycogen phosphorolysis improves memory formation of old animals. This could lead to the development of new strategies for treatment of age-related memory deficits., (© 2023 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
32. The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective.
- Author
-
Awashra M and Młynarz P
- Abstract
Nowadays, nanomaterials (NMs) are widely present in daily life due to their significant benefits, as demonstrated by their application in many fields such as biomedicine, engineering, food, cosmetics, sensing, and energy. However, the increasing production of NMs multiplies the chances of their release into the surrounding environment, making human exposure to NMs inevitable. Currently, nanotoxicology is a crucial field, which focuses on studying the toxicity of NMs. The toxicity or effects of nanoparticles (NPs) on the environment and humans can be preliminary assessed in vitro using cell models. However, the conventional cytotoxicity assays, such as the MTT assay, have some drawbacks including the possibility of interference with the studied NPs. Therefore, it is necessary to employ more advanced techniques that provide high throughput analysis and avoid interferences. In this case, metabolomics is one of the most powerful bioanalytical strategies to assess the toxicity of different materials. By measuring the metabolic change upon the introduction of a stimulus, this technique can reveal the molecular information of the toxicity induced by NPs. This provides the opportunity to design novel and efficient nanodrugs and minimizes the risks of NPs used in industry and other fields. Initially, this review summarizes the ways that NPs and cells interact and the NP parameters that play a role in this interaction, and then the assessment of these interactions using conventional assays and the challenges encountered are discussed. Subsequently, in the main part, we introduce the recent studies employing metabolomics for the assessment of these interactions in vitro ., Competing Interests: There are no conflicts to declare., (This journal is © The Royal Society of Chemistry.)
- Published
- 2023
- Full Text
- View/download PDF
33. UHPLC-ESI-MS/MS assay for quantification of endocannabinoids in cerebrospinal fluid using surrogate calibrant and surrogate matrix approaches.
- Author
-
Aydin E, Cebo M, Mielnik J, Richter H, Schüle R, Sievers-Engler A, Młynarz P, and Lämmerhofer M
- Subjects
- Humans, Aged, Middle Aged, Chromatography, High Pressure Liquid methods, Acetonitriles, Endocannabinoids metabolism, Tandem Mass Spectrometry methods
- Abstract
Endocannabinoids are endogenous lipids with the main function recognized to act as neuromodulators through their cannabinoid receptors. Dysregulation of the endocannabinoid system is implicated in various pathologies, such as inflammatory and neurodegenerative diseases. In this study we describe a sensitive UHPLC-MS/MS method for the analysis of trace levels of 7 endocannabinoids in cerebrospinal fluid samples. The analytes covered comprised 1- and 2-arachidonoylglycerol 1- and 2-AG (which were analysed as sum due to their interconversion), 2-arachidonylglycerol ether 2-AGE, anandamide AEA, N-linoleoyl ethanolamide LEA, N-palmitoyl ethanolamide PEA and N-oleoyl ethanolamide OEA. Analytes were extracted from the biofluid by a simple monophasic procedure involving protein precipitation with acetonitrile (MeCN). The analytical method is based on chromatographic separation of the analytes with solid-core (core-shell, superficially porous) particle column Cortecs C18+ . Gradient elution with changing proportion of water and acetonitrile and constant concentration of formic acid provided reasonable separation of analytes, close elution of analytes and their internal standards and minimized matrix effects in biological samples. For specific detection of the endocannabinoids a triple-quadrupole tandem mass spectrometer with electrospray ionisation (ESI) and selected reaction monitoring (SRM) mode was used, and it provided good assay selectivity. The developed method required a minute volume of the biological samples (50 µL) and achieved excellent sensitivity (the lower limit of detection was between 4.15 and 30.18 pM of the biological sample). Linear calibration was achieved in the range from 25 to 10,545 pM for AEA, 90-3802 pM for 1-AG, 90-724 pM for 2-AG, 12-5226 pM for LEA, 33-13,942 for OEA, 34-23,850 pM for 2-AGE, 72-30,190 for PEA and 10-4218 for AEA-d
4 in CSF. The method was validated and revealed relative errors in the range of - 14.7 to + 12.3% at LLOQ and - 14.1 to + 14.2% for the remaining validation range. Precisions were in the acceptable range (< 20% RSD at LLOQ, and <15% for the remaining levels) as well. It was finally used to quantify endocannabinoids in human cerebrospinal fluid obtained from 118 donors. Accurate quantification of endogenous compounds in biological samples was achieved by using two different principal approaches (surrogate matrix for AEA, 2-AG, OEA, 2-AGE, LEA and PEA, and surrogate calibrant for AEA only) and they were evaluated by use of the Passing-Bablok regression. Concentrations (median) of CSF samples of patients suffering from CNS infection and controls were found to be around 160 pM for 1- and 2-AG, 86 pM for AEA, 62 for 2-AGE, 58 for LEA, 93 pM for PEA, and 83 pM for OEA., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier B.V. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
34. Precision Nutrition in NAFLD: Effects of a High-Fiber Intervention on the Serum Metabolome of NAFD Patients-A Pilot Study.
- Author
-
Stachowska E, Maciejewska-Markiewicz D, Palma J, Mielko KA, Qasem B, Kozłowska-Petriczko K, Ufnal M, Sokolowska KE, Hawryłkowicz V, Załęska P, Jakubczyk K, Wunsch E, Ryterska K, Skonieczna-Żydecka K, and Młynarz P
- Subjects
- Adult, Humans, Pilot Projects, Nutritional Status, Diet, Metabolome, Non-alcoholic Fatty Liver Disease metabolism
- Abstract
Non-alcoholic fatty liver disease (NAFLD) is associated with dysfunction of the intestinal microbiota and its metabolites. We aimed to assess whether replacing bread with high-fiber buns beneficially changes the metabolome in NAFLD patients. This study involved 27 adult patients with NAFLD validated by FibroScan
® (CAP ≥ 234 dB/m). Patients were asked to replace their existing bread for two meals with high-fiber buns. In this way, the patients ate two rolls every day for 2 months. The following parameters were analysed (at the beginning and after 2 months): the anthropometric data (BIA), eating habits (24 h food recalls), gut barrier markers (lipopolysaccharide S and liposaccharide binding protein (LPS, LBP)), serum short-chain fatty acids (SCFAs) and branched chain fatty acids (BCFAs) by GC/MS chromatography, as well as serum metabolites (by1 H NMR spectroscopy). After 2 months of high-fiber roll consumption, the reduction of liver steatosis was observed (change Fibroscan CAP values from 309-277 dB/m). In serum propionate, acetate, isovaleric, and 2-methylbutyric decrease was observed. Proline, choline and one unknown molecule had higher relative concentration in serum at endpoint. A fiber-targeted dietary approach may be helpful in the treatment of patients with NAFLD, by changing the serum microbiota metabolome.- Published
- 2022
- Full Text
- View/download PDF
35. Hydrogel Alginate Seed Coating as an Innovative Method for Delivering Nutrients at the Early Stages of Plant Growth.
- Author
-
Skrzypczak D, Jarzembowski Ł, Izydorczyk G, Mikula K, Hoppe V, Mielko KA, Pudełko-Malik N, Młynarz P, Chojnacka K, and Witek-Krowiak A
- Abstract
Seed coating containing fertilizer nutrients and plant growth biostimulants is an innovative technique for precision agriculture. Nutrient delivery can also be conducted through multilayer seed coating. For this purpose, sodium alginate with NPK, which was selected in a preliminary selection study, crosslinked with divalent ions (Cu(II), Mn(II), Zn(II)) as a source of fertilizer micronutrients, was used to produce seed coating. The seeds were additionally coated with a solution containing amino acids derived from high-protein material. Amino acids can be obtained by alkaline hydrolysis of mealworm larvae (Gly 71.2 ± 0.6 mM, Glu 55.8 ± 1.3 mM, Pro 48.8 ± 1.5 mM, Ser 31.4 ± 1.5 mM). The formulations were applied in different doses per 100 g of seeds: 35 mL, 70 mL, 105 mL, and 140 mL. SEM-EDX surface analysis showed that 70 mL of formulation/100 g of seeds formed a continuity of coatings but did not result in a uniform distribution of components on the surface. Extraction tests proved simultaneous low leaching of nutrients into water (max. 10%), showing a slow release pattern. There occurred high bioavailability of fertilizer nutrients (even up to 100%). Pot tests on cucumbers ( Cornichon de Paris ) confirmed the new method's effectiveness, yielding a 50% higher fresh sprout weight and four times greater root length than uncoated seeds. Seed coating with hydrogel has a high potential for commercial application, stimulating the early growth of plants and thus leading to higher crop yields.
- Published
- 2021
- Full Text
- View/download PDF
36. Effect of 6-Month Feeding with a Diet Enriched in EPA + DHA from Fish Meat on the Blood Metabolomic Profile of Dogs with Myxomatous Mitral Valve Disease.
- Author
-
Pasławski R, Kurosad A, Ząbek A, Pasławska U, Noszczyk-Nowak A, Michałek M, and Młynarz P
- Abstract
Animal nutrition plays an important role in the therapy of many diseases, including heart failure. The aim was to assess whether 6 months of feeding an AEP + ADH enriched diet (from fish meat) in dogs suffering from heart failure due to mitral degeneration impacts the dogs' metabolic profile and clinical status. Twenty small breed dogs were included: 50% were in stage B2 of MMVD and 50%, in stage C according to ACVIM. Dogs were randomly divided into two groups. One group receiving a standard diet, the second one a diet enriched with EPA + DHA (from fish meat). All dogs continued to receive appropriate therapy throughout the study. Control examinations were performed at the start of the study, after 3 and 6 months of appropriate feeding. Examinations included ECG, ECHO, blood hemathology and biochemistry, morphometric measurements, body fat index and subcutaneous fat tissue thickness. Serum samples were analyzed with a high-performance liquid chromatography system. Data were analyzed using the Progenesis QI (PQI, Non-linear Dynamics). The results showed no differences in clinical, cardiological, haematological and biochemical parameters between the two study groups. An effect on the metabolomic profile following a continued diet enriched in DHA + EPA (from fish meat) was more pronounced with time. After 6 months of feeding the diete enriched with DHA + EPA (from fish meat), there was a favorable reduction in glycerophosphocholine and xanthine levels, but an adverse increase in lactate and furvan and a decrease in alanine was not stopped.
- Published
- 2021
- Full Text
- View/download PDF
37. Gender-Specific Metabolomics Approach to Kidney Cancer.
- Author
-
Deja S, Litarski A, Mielko KA, Pudełko-Malik N, Wojtowicz W, Zabek A, Szydełko T, and Młynarz P
- Abstract
Renal cell carcinoma (RCC) is the most common form of kidney malignancy. RCC is more common among men with a 2/1 male/female incidence ratio worldwide. Given the underlying epidemiological differences in the RCC incidence between males and females, we explored the gender specific
1 H NMR serum metabolic profiles of RCC patients and their matched controls. A number of differential metabolites were shared by male and female RCC patients. These RCC specific changes included lower lactate, threonine, histidine, and choline levels together with increased levels of pyruvate, N -acetylated glycoproteins, beta-hydroxybutyrate, acetoacetate, and lysine. Additionally, serum lactate/pyruvate ratio was a strong predictor of RCC status regardless of gender. Although only moderate changes in metabolic profiles were observed between control males and females there were substantial gender related differences among RCC patients. Gender specific metabolic features associated with RCC status were identified suggesting that different metabolic panels could be leveraged for a more precise diagnostic.- Published
- 2021
- Full Text
- View/download PDF
38. Metabolomics Comparison of Drug-Resistant and Drug-Susceptible Pseudomonas aeruginosa Strain (Intra- and Extracellular Analysis).
- Author
-
Mielko KA, Jabłoński SJ, Pruss Ł, Milczewska J, Sands D, Łukaszewicz M, and Młynarz P
- Subjects
- Humans, Pseudomonas Infections drug therapy, Pseudomonas Infections microbiology, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa isolation & purification, Anti-Bacterial Agents pharmacology, Drug Resistance, Multiple, Bacterial, Metabolome drug effects, Pseudomonas Infections metabolism, Pseudomonas aeruginosa metabolism
- Abstract
Pseudomonas aeruginosa is a common human pathogen belonging to the ESKAPE group. The multidrug resistance of bacteria is a considerable problem in treating patients and may lead to increased morbidity and mortality rate. The natural resistance in these organisms is caused by the production of specific enzymes and biofilm formation, while acquired resistance is multifactorial. Precise recognition of potential antibiotic resistance on different molecular levels is essential. Metabolomics tools may aid in the observation of the flux of low molecular weight compounds in biochemical pathways yielding additional information about drug-resistant bacteria. In this study, the metabolisms of two P. aeruginosa strains were compared-antibiotic susceptible vs. resistant. Analysis was performed on both intra- and extracellular metabolites. The
1 H NMR method was used together with multivariate and univariate data analysis, additionally analysis of the metabolic pathways with the FELLA package was performed. The results revealed the differences in P. aeruginosa metabolism of drug-resistant and drug-susceptible strains and provided direct molecular information about P. aeruginosa response for different types of antibiotics. The most significant differences were found in the turnover of amino acids. This study can be a valuable source of information to complement research on drug resistance in P. aeruginosa .- Published
- 2021
- Full Text
- View/download PDF
39. Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies.
- Author
-
Bogunia-Kubik K, Wojtowicz W, Swierkot J, Mielko KA, Qasem B, Wielińska J, Sokolik R, Pruss Ł, and Młynarz P
- Subjects
- Adult, Arthritis, Psoriatic drug therapy, Arthritis, Rheumatoid drug therapy, Cohort Studies, Computational Biology, Female, Humans, Magnetic Resonance Spectroscopy, Male, Metabolome, Principal Component Analysis, Spondylitis, Ankylosing drug therapy, Arthritis, Psoriatic blood, Arthritis, Rheumatoid blood, Ethanol blood, Spondylitis, Ankylosing blood, Tumor Necrosis Factor Inhibitors therapeutic use
- Abstract
Rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA) are comprehensive immunological disorders. The treatment of these disorders is limited to ameliorating the symptoms and improving the quality of life of patients. In this study, serum samples from RA, AS, and PsA patients were analyzed with metabolomic tools employing the 1H NMR method in combination with univariate and multivariate analyses. The results obtained in this study showed that the changes in metabolites were the highest for AS > RA > PsA. The study demonstrated that the time until remission or until low disease activity is achieved is shortest (approximately three months) for AS, longer for RA and longest for PsA. The statistically common metabolite that was found to be negatively correlated with the healing processes of these disorders is ethanol, which may indicate the involvement of the gut microflora and/or the breakdown of malondialdehyde as a cell membrane lipid peroxide product.
- Published
- 2021
- Full Text
- View/download PDF
40. Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression.
- Author
-
Warowicka A, Qasem B, Dera-Szymanowska A, Wołuń-Cholewa M, Florczak P, Horst N, Napierała M, Szymanowski K, Popenda Ł, Bartkowiak G, Florek E, Goździcka-Józefiak A, and Młynarz P
- Abstract
Endometriosis is a gynecological disease defined by the presence of endometrial tissue outside the uterus. To date, the effective treatment of this disease is still based on invasive surgery or laparoscopy. Chelidonium majus L. (Papaveraceae) belongs to medicinal, latex-bearing plants. Extracts from the plant are a rich source of pharmacologically active agents. Protoberberine compounds derived from C. majus possess anticancer and antiproliferative activities. In the present study of a rat model of endometriosis, we investigated the influence of the plant protoberberine-rich fraction (BBR) obtained from the medicinal plant C. majus on the development of endometriosis. To understand of BBR therapeutic potential for endometriosis, metabolomics has been applied to study. BBR was prepared from an ethanolic extract of dry plants C. majus . Rats ( n = 16) with confirmed endometriosis were treated with BBR administered orally (1 g/kg) for 14 days. Blood serum samples were collected from all of the animals and metabolites were studied using the NMR method. The metabolomic pattern was compared before and after the protoberberine treatment. The performed analysis showed significant changes in the concentrations of metabolites that are involved in energy homeostasis, including glucose, glutamine, and lactate. Histopathological studies showed no recurrence of endometriosis loci after treatment with BBR. The results of the study found that BBR treatment prevents the recurrence of endometriosis in rats. Moreover, metabolomics profiling can be applied to better understand the mechanisms of action of these protoberberine secondary plant metabolites. Our findings provide new insights into the pharmaceutical activity of natural protoberberine plant compounds.
- Published
- 2021
- Full Text
- View/download PDF
41. Possible metabolic switch between environmental and pathogenic Pseudomonas aeruginosa strains: 1 H NMR based metabolomics study.
- Author
-
Mielko KA, Jabłoński SJ, Wojtowicz W, Milczewska J, Sands D, Łukaszewicz M, and Młynarz P
- Subjects
- Humans, Metabolomics, Proton Magnetic Resonance Spectroscopy, Pseudomonas aeruginosa, Cystic Fibrosis, Pseudomonas Infections
- Abstract
The study aimed to assess whether Pseudomonas aeruginosa strains from different sources can be distinguished by the metabolomic fingerprint and to check whether antibiotic susceptibility distinctions are available through metabolomic analysis.
1 H NMR spectroscopy analysis of the bacteria metabolites was performed. Twenty-nine strains were tested (18 isolated form cystic fibrosis patients and 11 environmental). Thirty-one metabolites were identified, 12 were up-regulated in strains from CF patients, while 2 were higher level in strains from the environment. Changed carbohydrate catabolic metabolism and the metabolic shift toward the utilization of amino acids is suggested in strains from CF patients., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
42. An Optimization of Liquid-Liquid Extraction of Urinary Volatile and Semi-Volatile Compounds and Its Application for Gas Chromatography-Mass Spectrometry and Proton Nuclear Magnetic Resonance Spectroscopy.
- Author
-
Drabińska N, Młynarz P, de Lacy Costello B, Jones P, Mielko K, Mielnik J, Persad R, and Ratcliffe NM
- Subjects
- Female, Humans, Gas Chromatography-Mass Spectrometry methods, Liquid-Liquid Extraction methods, Liquid-Liquid Extraction standards, Proton Magnetic Resonance Spectroscopy methods, Urinalysis methods, Volatile Organic Compounds urine
- Abstract
Urinary volatile compounds (VCs) have been recently assessed for disease diagnoses. They belong to very diverse chemical classes, and they are characterized by different volatilities, polarities and concentrations, complicating their analysis via a single analytical procedure. There remains a need for better, lower-cost methods for VC biomarker discovery. Thus, there is a strong need for alternative methods, enabling the detection of a broader range of VCs. Therefore, the main aim of this study was to optimize a simple and reliable liquid-liquid extraction (LLE) procedure for the analysis of VCs in urine using gas chromatography-mass spectrometry (GC-MS), in order to obtain the maximum number of responses. Extraction parameters such as pH, type of solvent and ionic strength were optimized. Moreover, the same extracts were analyzed using Proton Nuclear Magnetic Resonance Spectroscopy (
1 H-NMR), to evaluate the applicability of a single urine extraction for multiplatform purposes. After the evaluation of experimental conditions, an LLE protocol using 2 mL of urine in the presence of 2 mL of 1 M sulfuric acid and sodium sulphate extracted with dichloromethane was found to be optimal. The optimized method was validated with the external standards and was found to be precise and linear, and allowed for detection of >400 peaks in a single run present in at least 50% of six samples-considerably more than the number of peaks detected by solid-phase microextracton fiber pre-concentration-GC-MS (328 ± 6 vs. 234 ± 4).1 H-NMR spectroscopy of the polar and non-polar extracts extended the range to >40 more (mainly low volatility compounds) metabolites (non-destructively), the majority of which were different from GC-MS. The more peaks detectable, the greater the opportunity of assessing a fingerprint of several compounds to aid biomarker discovery. In summary, we have successfully demonstrated the potential of LLE as a cheap and simple alternative for the analysis of VCs in urine, and for the first time the applicability of a single urine solvent extraction procedure for detecting a wide range of analytes using both GC-MS and1 H-NMR analysis to enhance putative biomarker detection. The proposed method will simplify the transport between laboratories and storage of samples, as compared to intact urine samples.- Published
- 2020
- Full Text
- View/download PDF
43. Imunofan-RDKVYR Peptide-Stimulates Skin Cell Proliferation and Promotes Tissue Repair.
- Author
-
Sawicka J, Dzierżyńska M, Wardowska A, Deptuła M, Rogujski P, Sosnowski P, Filipowicz N, Mieczkowska A, Sass P, Pawlik A, Hać A, Schumacher A, Gucwa M, Karska N, Kamińska J, Płatek R, Mazuryk J, Zieliński J, Kondej K, Młynarz P, Mucha P, Skowron P, Janus Ł, Herman-Antosiewicz A, Sachadyn P, Czupryn A, Piotrowski A, Pikuła M, and Rodziewicz-Motowidło S
- Subjects
- Albumins metabolism, Animals, Basophils drug effects, Cell Death drug effects, Cell Line, Chemotaxis drug effects, Cytokines metabolism, DNA Methylation drug effects, Ear pathology, Fibroblasts cytology, Fibroblasts drug effects, HaCaT Cells cytology, HaCaT Cells drug effects, Humans, Injections, Subcutaneous, Mice, Inbred BALB C, Mice, Inbred C57BL, Oligopeptides blood, Oligopeptides chemistry, Oligopeptides metabolism, Protein Stability drug effects, Stem Cells cytology, Stem Cells drug effects, Transcription, Genetic drug effects, Cell Proliferation drug effects, Oligopeptides pharmacology, Skin pathology, Wound Healing
- Abstract
Regeneration and wound healing are vital to tissue homeostasis and organism survival. One of the biggest challenges of today's science and medicine is finding methods and factors to stimulate these processes in the human body. Effective solutions to promote regenerative responses will accelerate advances in tissue engineering, regenerative medicine, transplantology, and a number of other clinical specialties. In this study, we assessed the potential efficacy of a synthetic hexapeptide, RDKVYR, for the stimulation of tissue repair and wound healing. The hexapeptide is marketed under the name "Imunofan" (IM) as an immunostimulant. IM displayed stability in aqueous solutions, while in plasma it was rapidly bound by albumins. Structural analyses demonstrated the conformational flexibility of the peptide. Tests in human fibroblast and keratinocyte cell lines showed that IM exerted a statistically significant ( p < 0.05) pro-proliferative activity (30-40% and 20-50% increase in proliferation of fibroblast and keratinocytes, respectively), revealed no cytotoxicity over a vast range of concentrations ( p < 0.05), and had no allergic properties. IM was found to induce significant transcriptional responses, such as enhanced activity of genes involved in active DNA demethylation ( p < 0.05) in fibroblasts and activation of genes involved in immune responses, migration, and chemotaxis in adipose-derived stem cells derived from surgery donors. Experiments in a model of ear pinna injury in mice indicated that IM moderately promoted tissue repair (8% in BALB/c and 36% in C57BL/6 in comparison to control).
- Published
- 2020
- Full Text
- View/download PDF
44. LC-QTOF-MS and 1 H NMR Metabolomics Verifies Potential Use of Greater Omentum for Klebsiella pneumoniae Biofilm Eradication in Rats.
- Author
-
Teul J, Deja S, Celińska-Janowicz K, Ząbek A, Młynarz P, Barć P, Junka A, Smutnicka D, Bartoszewicz M, Pałka J, and Miltyk W
- Abstract
Bacterial wound infections are a common problem associated with surgical interventions. In particular, biofilm-forming bacteria are hard to eradicate, and alternative methods of treatment based on covering wounds with vascularized flaps of tissue are being developed. The greater omentum is a complex organ covering the intestines in the abdomen, which support wound recovery following surgical procedures and exhibit natural antimicrobial activity that could improve biofilm eradication. We investigated changes in rats' metabolome following Klebsiella pneumoniae infections, as well as the greater omentum's ability for Klebsiella pneumoniae biofilm eradication. Rats received either sterile implants or implants covered with Klebsiella pneumoniae biofilm (placed in the peritoneum or greater omentum). Metabolic profiles were monitored at days 0, 2, and 5 after surgery using combined proton nuclear magnetic resonance (
1 H NMR) and high performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (LC-QTOF‑MS) measurements of urine samples followed by chemometric analysis. Obtained results indicated that grafting of the sterile implant to the greater omentum did not cause major disturbances in rats' metabolism, whereas the sterile implant located in the peritoneum triggered metabolic perturbations related to tricarboxylic acid (TCA) cycle, as well as choline, tryptophan, and hippurate metabolism. Presence of implants colonized with Klebsiella pneumoniae biofilm resulted in similar levels of metabolic perturbations in both locations. Our findings confirmed that surgical procedures utilizing the greater omentum may have a practical use in wound healing and tissue regeneration in the future.- Published
- 2020
- Full Text
- View/download PDF
45. Evaluation of MDA-MB-468 Cell Culture Media Analysis in Predicting Triple-Negative Breast Cancer Patient Sera Metabolic Profiles.
- Author
-
Wojtowicz W, Wróbel A, Pyziak K, Tarkowski R, Balcerzak A, Bębenek M, and Młynarz P
- Abstract
Triple-negative breast cancer (TNBC) is characterized by limited survival, poor prognosis, and high recurrence. Understanding the metabolic adaptations of TNBC could help reveal improved treatment regiments. Here we performed a comprehensive
1 H NMR metabolic characterization of the MDA-MB-468 cell line, a commonly used model of TNBC, followed by an analysis of serum samples obtained from TNBC patients and healthy controls. MDA-MB-468 cells were cultured, and changes in the metabolic composition of the medium were monitored for 72 h. Based on time courses, metabolites were categorized as being consumed, being produced, or showing a mixed behavior. When comparing TNBC and control samples (HC), and by using multivariate and univariate analyses, we identified nine metabolites with differing profiles). The serum of TNBC patients was characterized by higher levels of glucose, glutamine, citrate, and acetoacetate and by lower levels of lactate, alanine, tyrosine, glutamate, and acetone. A comparative analysis between MDA-MB-468 cell culture media and TNBC patients' serum identified a potential systemic response to the carcinogenesis-associated processes, highlighting that MDA-MB-468 cells footprint does not reflect metabolic changes observed in studied TNBC serum fingerprint., Competing Interests: The authors declare that they have no competing interests.- Published
- 2020
- Full Text
- View/download PDF
46. Serine Biosynthesis Pathway Supports MYC-miR-494-EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells.
- Author
-
Białopiotrowicz E, Noyszewska-Kania M, Kachamakova-Trojanowska N, Łoboda A, Cybulska M, Grochowska A, Kopczyński M, Mikula M, Prochorec-Sobieszek M, Firczuk M, Graczyk-Jarzynka A, Zagożdżon R, Ząbek A, Młynarz P, Dulak J, Górniak P, Szydłowski M, Pyziak K, Martyka J, Sroka-Porada A, Jabłońska E, Polak A, Kowalczyk P, Szumera-Ciećkiewicz A, Chapuy B, Rzymski T, Brzózka K, and Juszczyński P
- Abstract
Burkitt lymphoma (BL) is a rapidly growing tumor, characterized by high anabolic requirements. The MYC oncogene plays a central role in the pathogenesis of this malignancy, controlling genes involved in apoptosis, proliferation, and cellular metabolism. Serine biosynthesis pathway (SBP) couples glycolysis to folate and methionine cycles, supporting biosynthesis of certain amino acids, nucleotides, glutathione, and a methyl group donor, S-adenosylmethionine (SAM). We report that BLs overexpress SBP enzymes, phosphoglycerate dehydrogenase (PHGDH) and phosphoserine aminotransferase 1 (PSAT1). Both genes are controlled by the MYC-dependent ATF4 transcription factor. Genetic ablation of PHGDH/PSAT1 or chemical PHGDH inhibition with NCT-503 decreased BL cell lines proliferation and clonogenicity. NCT-503 reduced glutathione level, increased reactive oxygen species abundance, and induced apoptosis. Consistent with the role of SAM as a methyl donor, NCT-503 decreased DNA and histone methylation, and led to the re-expression of ID4 , KLF4 , CDKN2B and TXNIP tumor suppressors. High H3K27me3 level is known to repress the MYC negative regulator miR-494. NCT-503 decreased H3K27me3 abundance, increased the miR-494 level, and reduced the expression of MYC and MYC-dependent histone methyltransferase, EZH2. Surprisingly, chemical/genetic disruption of SBP did not delay BL and breast cancer xenografts growth, suggesting the existence of mechanisms compensating the PHGDH/PSAT1 absence in vivo., Competing Interests: P. Juszczynski is a member of the Scientific Advisory Board at Selvita S.A. and served as a consultant for Selvita S.A. Dr. T. Rzymski, Dr. K. Brzozka and P. Kowalczyk are Selvita S.A. employees.
- Published
- 2020
- Full Text
- View/download PDF
47. Proteome of cat semen obtained after urethral catheterization.
- Author
-
Mogielnicka-Brzozowska M, Prochowska S, Niżański W, Bromke MA, Wiśniewski J, Olejnik B, Kuzborska A, Fraser L, Młynarz P, and Kordan W
- Subjects
- Animals, Gene Expression Regulation, Male, Signal Transduction, Spermatozoa metabolism, Cats, Proteome metabolism, Semen physiology, Semen Analysis veterinary, Urinary Catheterization veterinary
- Abstract
The binding of seminal plasma (SP) proteins by spermatozoa plays an important role in the regulation of sperm epididymal maturation, motility gaining in female reproductive tracts and sperm-egg interaction. The aim of the study was to analyze the SP and sperm extracts proteome of cat (Felis catus) semen. The seminal plasma and spermatozoa were obtained by urethra catheterization from 10 male cats. Proteins were extracted using RIPA buffer and separated by electrophoresis (SDS-PAGE). The gels were analyzed using MultiAnalyst software. The proteins were subsequently analyzed using NanoUPLC-Q-TOF/MS. UniProt database-supported identification resulted in 106 proteins identified in the cat SP and 98 proteins in the extracts of spermatozoa. Based on a gene ontology analysis, dominant molecular functions of feline SP proteins were binding, catalytic, and antioxidant activity (56%, 33%, and 11% of cases, respectively). The molecular functions of sperm extracts proteins were mainly involved in catalytic activity (41%) and binding (23%). The proteins present in both, the SP and spermatozoa's extracts, were: serum albumin (ALB), semenogelin 2 (SEMG 2), clusterin (CLU), lactoferrin (LTF), prostatic acid phosphatase (ACPP), prolactin inducible protein (PIP), negative elongation factor E (NELF-E) and ectonucleotide pyrophosphatase (ENPP3). Protein-protein interactions analysis showed significant connection for 12 proteins in the cat semen. The seminal plasma proteins which, with high probability score, participate in important metabolic pathways are: glutathione peroxidases (GPx5 and 6), prostatic acid phosphatase (ACPP), β-hexosaminidase (HEXB), polymeric immunoglobulin receptor (pIgR) and serpin family F member 1 (SERPINF1). For sperm protein extracts it were: pyruvate dehydrogenase (PDHB), succinate-CoA-ligase (SUCLA2), malate dehydrogenase (MDH2), ATP synthase F1 subunit alpha (ATP5F1A) and tubulin beta (TUBB)., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
48. N-phosphonomethylglycine utilization by the psychrotolerant yeast Solicoccozyma terricola M 3.1.4.
- Author
-
Stosiek N, Terebieniec A, Ząbek A, Młynarz P, Cieśliński H, and Klimek-Ochab M
- Subjects
- DNA, Fungal, Glycine chemistry, Organophosphonates metabolism, Oxidoreductases metabolism, Phosphorus metabolism, Phylogeny, Yeasts genetics, Glyphosate, Glycine analogs & derivatives, Glycine metabolism, Yeasts metabolism
- Abstract
Solicoccozyma terricola M 3.1.4., the yeast strain isolated from soil sample from blueberry cultivation in Miedzyrzec Podlaski in Poland, is capable to split of phosphorus to nitrogen and nitrogen to carbon bonds in N-phosphonomethylglycine (PMG, glyphosate). The biodegradation process proceeds in the phosphate-independent manner. It is the first example of a psychrotolerant yeast strain able to degrade PMG via CN bond cleavage accompanied by AMPA formation and not like in most microorganisms via CP bond disruption followed by the sarcosine pathway. Glyphosate oxidoreductase (GOX) type activity was detected in cell-free extracts prepared from S. terricola M 3.1.4. pregrown on 4 mM PMG as a sole phosphorus and nitrogen source in cultivation medium., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
49. Serum NMR metabolomics to differentiate haematologic malignancies.
- Author
-
Wojtowicz W, Chachaj A, Olczak A, Ząbek A, Piątkowska E, Rybka J, Butrym A, Biedroń M, Mazur G, Wróbel T, Szuba A, and Młynarz P
- Abstract
Haematological malignancies are a frequently diagnosed group of neoplasms and a significant cause of cancer deaths. The successful treatment of these diseases relies on early and accurate detection. Specific small molecular compounds released by malignant cells and the simultaneous response by the organism towards the pathological state may serve as diagnostic/prognostic biomarkers or as a tool with relevance for cancer therapy management. To identify the most important metabolites required for differentiation, an
1 H NMR metabolomics approach was applied to selected haematological malignancies. This study utilized 116 methanol serum extract samples from AML (n= 38), nHL (n= 26), CLL (n= 21) and HC (n= 31). Multivariate and univariate data analyses were performed to identify the most abundant changes among the studied groups. Complex and detailed VIP-PLS-DA models were calculated to highlight possible changes in terms of biochemical pathways and discrimination ability. Chemometric model prediction properties were validated by receiver operating characteristic (ROC) curves and statistical analysis. Two sets of eight important metabolites in HC/AML/CLL/nHL comparisons and five in AML/CLL/nHL comparisons were selected to form complex models to represent the most significant changes that occurred., Competing Interests: CONFLICTS OF INTEREST The authors declare that they have no competing interests.- Published
- 2018
- Full Text
- View/download PDF
50. Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency.
- Author
-
Mika A, Wojtowicz W, Ząbek A, Młynarz P, Chmielewski M, Sledzinski T, and Stepnowski P
- Subjects
- Aged, Disease Progression, Female, Glomerular Filtration Rate, Humans, Male, Metabolic Diseases blood, Metabolome, Middle Aged, Multivariate Analysis, Principal Component Analysis, Renal Insufficiency, Chronic blood, Metabolic Diseases metabolism, Metabolic Networks and Pathways, Metabolomics methods, Proton Magnetic Resonance Spectroscopy methods, Renal Insufficiency, Chronic metabolism
- Abstract
Chronic kidney disease (CKD) is one of the major problems of modern medicine and a huge socioeconomic burden. Thorough knowledge of metabolic alterations associated with this condition is vital to prevent its progression. However, still little is known about metabolic disorders associated with CKD. In this study, we used
1 H NMR spectroscopy and multivariate analysis to identify alterations in serum metabolites of patients with various stages of CKD.1 H NMR spectroscopy followed by multivariate analysis showed that CKD patients differed from the controls in terms of 15 endogenous metabolites, and MetPA analysis demonstrated significant intergroup differences in 5 potential target pathways and 14 metabolites. Owing a good performance of discriminant models, these findings suggest that CKD patients and healthy controls differ in terms of their metabolic fingerprints. In turn, the results of MetPA analysis imply that CKD and its progression exert an effect on selected metabolic pathways. This study provided a better insight into metabolic alterations associated with CKD, and identified some target pathways that can be potentially modified to slow down the progression of this serious and debilitating disease., (Copyright © 2017 Elsevier B.V. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.